99 related articles for article (PubMed ID: 31784089)
1. Combination of MEK1/2 inhibitor and LXR ligand synergistically inhibit atherosclerosis in LDLR deficient mice.
Yang J; Liu L; Yang X; Duan Y; Zeng P; Yang S; Ma C; Li X; Han J; Chen Y
Biochem Biophys Res Commun; 2020 Feb; 522(2):512-517. PubMed ID: 31784089
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of notch enhances the anti-atherosclerotic effects of LXR agonists while reducing fatty liver development in ApoE-deficient mice.
Hao Y; Wang X; Zhang F; Wang M; Wang Y; Wang H; Du Y; Wang T; Fu F; Gao Z; Zhang L
Toxicol Appl Pharmacol; 2020 Nov; 406():115211. PubMed ID: 32853627
[TBL] [Abstract][Full Text] [Related]
4. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
[TBL] [Abstract][Full Text] [Related]
5. MEK1/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-An anti-atherogenic function of ERK1/2 inhibition.
Zhang L; Chen Y; Yang X; Yang J; Cao X; Li X; Li L; Miao QR; Hajjar DP; Duan Y; Han J
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1180-1191. PubMed ID: 27365310
[TBL] [Abstract][Full Text] [Related]
6. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.
Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J
J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759
[TBL] [Abstract][Full Text] [Related]
7. Targeting macrophage liver X receptors by hydrogel-encapsulated T0901317 reduces atherosclerosis without effect on hepatic lipogenesis.
Ma C; Feng K; Yang X; Yang Z; Wang Z; Shang Y; Fan G; Liu L; Yang S; Li X; Han J; Duan Y; Chen Y
Br J Pharmacol; 2021 Apr; 178(7):1620-1638. PubMed ID: 33506494
[TBL] [Abstract][Full Text] [Related]
8. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317.
Peng D; Hiipakka RA; Reardon CA; Getz GS; Liao S
Atherosclerosis; 2009 Mar; 203(1):59-66. PubMed ID: 18639878
[TBL] [Abstract][Full Text] [Related]
9. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice.
Peng D; Hiipakka RA; Xie JT; Dai Q; Kokontis JM; Reardon CA; Getz GS; Liao S
Br J Pharmacol; 2011 Apr; 162(8):1792-804. PubMed ID: 21232031
[TBL] [Abstract][Full Text] [Related]
10. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
11. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.
Okazaki H; Goldstein JL; Brown MS; Liang G
J Biol Chem; 2010 Feb; 285(9):6801-10. PubMed ID: 20037162
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production.
Ma X; Wang Q; Liu Y; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao RQ; Duan Y; Han J
Int J Cancer; 2015 Feb; 136(4):771-83. PubMed ID: 24947959
[TBL] [Abstract][Full Text] [Related]
13. Impaired adipose expansion caused by liver X receptor activation is associated with insulin resistance in mice fed a high-fat diet.
Dong Y; Xu Z; Zhang Z; Yin X; Lin X; Li H; Zheng F
J Mol Endocrinol; 2017 Apr; 58(3):141-154. PubMed ID: 28258092
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice.
Eussen SR; Rompelberg CJ; Andersson KE; Klungel OH; Hellstrand P; Oste R; van Kranen H; Garssen J
Pharmacol Res; 2011 Jul; 64(1):36-43. PubMed ID: 21371558
[TBL] [Abstract][Full Text] [Related]
15. MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis.
Yan Y; Zhu M; Ma J; He X; Yang X; Xu H; Jiang M; Zhang S; Duan Y; Han J; Chen Y
Bioengineered; 2022 Apr; 13(4):11214-11227. PubMed ID: 35485167
[TBL] [Abstract][Full Text] [Related]
16. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
[TBL] [Abstract][Full Text] [Related]
18. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
[TBL] [Abstract][Full Text] [Related]
19. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice.
Tang K; Wang F; Zeng Y; Chen X; Xu X
Eur J Pharmacol; 2018 Jul; 830():76-86. PubMed ID: 29704496
[TBL] [Abstract][Full Text] [Related]
20. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
